Filip Ottosson

Jan 17, 2025 | nature.com | Cristina Legido-Quigley |Timo Minssen |Filip Ottosson |Peter Rossing

Contemporary healthcare is undergoing a transition, shifting from a population-based approach to personalized medicine on an individual level1. In October 2023, the European Partnership for Personalized Medicine was officially launched2 to communicate the benefits of this approach to citizens and healthcare systems in member countries. The main debate revolves around the inconsistency in regulatory changes within personal data access and its potential commercialization.

Oct 28, 2024 | onlinelibrary.wiley.com | Anna Dieden |Nicolas Girerd |Université de Lorraine |Filip Ottosson

Introduction The progression from a healthy to a failing heart involves complex molecular, cellular, and physiological adaptations to cardiac stressors.

May 3, 2023 | nature.com | Roderick C. Slieker |Eleni Georgiadou |Giuseppe Giordano |Emma Ahlqvist |Ashfaq Ansari Ali |Karina Banasik | +22 more

Discovery cohorts Summary statistics of lipidomic, proteomic and metabolomic data is available from a Shiny dashboard available from: https://rhapdata-app.vital-it.ch. The generated metabolomic, lipidomic and proteomic data in DCS, GoDARTS and ANDIS are considered sensitive patient data and can therefore not be publicly available in compliance with the European privacy regulations governed by GDPR and according to limitations included in the informed consents signed by the study participants.